<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ppharm</journal-id><journal-title-group><journal-title xml:lang="ru">Педиатрическая фармакология</journal-title><trans-title-group xml:lang="en"><trans-title>Pediatric pharmacology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1727-5776</issn><issn pub-type="epub">2500-3089</issn><publisher><publisher-name>Издательство «ПедиатрЪ»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15690/pf.v12i2/1275</article-id><article-id custom-type="elpub" pub-id-type="custom">ppharm-1</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>ОЦЕНКА ПО ДАННЫМ МАГНИТНО-РЕЗОНАНСНОЙ ТОМОГРАФИИ В ДИНАМИКЕ ЭФФЕКТИВНОСТИ ПРОФИЛАКТИЧЕСКОЙ ЗАМЕСТИТЕЛЬНОЙ ТЕРАПИИ У ДЕТЕЙ С ГЕМОФИЛИЧЕСКОЙ АРТРОПАТИЕЙ</article-title><trans-title-group xml:lang="en"><trans-title>EVALUATING THE EFFECTIVENESS OF PROPHYLACTIC REPLACEMENT THERAPY IN CHILDREN WITH HEMOPHILIC ARTHROPATHY IN DYNAMICS ON MAGNETIC RESONANCE IMAGING</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ремзанцева</surname><given-names>И. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Remzantseva</surname><given-names>I. S.</given-names></name></name-alternatives><email xlink:type="simple">remzantseva@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Завадовская</surname><given-names>В. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Zavadovskaya</surname><given-names>V. D.</given-names></name></name-alternatives><email xlink:type="simple">remzantseva@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Огородова</surname><given-names>Л. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Ogorodova</surname><given-names>L. M.</given-names></name></name-alternatives><email xlink:type="simple">remzantseva@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Маевская</surname><given-names>З. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Maevskaya</surname><given-names>Z. A.</given-names></name></name-alternatives><email xlink:type="simple">remzantseva@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Килина</surname><given-names>О. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Kilina</surname><given-names>O. Yu.</given-names></name></name-alternatives><email xlink:type="simple">remzantseva@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кайлина</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Kailina</surname><given-names>A. N.</given-names></name></name-alternatives><bio xml:lang="en"/><email xlink:type="simple">remzantseva@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Сибирский государственный медицинский университет, Томск, Российская Федерация</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Siberian state medical university, Tomsk, Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Хакасский государственный университет им. Н.Ф. Катанова, Абакан, Российская Федерация</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Khakass state University named. N.F. Katanov, Abakan, Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2015</year></pub-date><pub-date pub-type="epub"><day>01</day><month>03</month><year>2015</year></pub-date><volume>12</volume><issue>2</issue><issue-title>Педиатрическая фармакология</issue-title><fpage>137</fpage><lpage>142</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ремзанцева И.С., Завадовская В.Д., Огородова Л.М., Маевская З.А., Килина О.Ю., Кайлина А.Н., 2015</copyright-statement><copyright-year>2015</copyright-year><copyright-holder xml:lang="ru">Ремзанцева И.С., Завадовская В.Д., Огородова Л.М., Маевская З.А., Килина О.Ю., Кайлина А.Н.</copyright-holder><copyright-holder xml:lang="en">Remzantseva I.S., Zavadovskaya V.D., Ogorodova L.M., Maevskaya Z.A., Kilina O.Y., Kailina A.N.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.pedpharma.ru/jour/article/view/1">https://www.pedpharma.ru/jour/article/view/1</self-uri><abstract><p>Изменение принципов лечения гемофилической артропатии позволило по-новому оценить роль методов лучевой диагностики. Различные диагностикумы используются не только для констатации степени поражения суставов, но и для оценки состояния суставов в динамике, достаточности и эффективности проводимой терапии. Цель исследования. Оценить в динамике с помощью магнитно-резонансной томографии (МРТ) состояние суставов у детей с гемофилической артропатией, получающих профилактическую заместительную терапию концентрированным фактором свертывая VIII. Пациенты и методы. В исследовании приняли участие 13 мальчиков с гемофилией типа А ― тяжелой формой заболевания (дефицит фактора VIII &lt; 1%) ― в возрасте от 5 до 14 лет (средний возраст 8,9 года) на момент начала исследования. Средний возраст появления гемартрозов ― 2,1 года (от 1,8 до 2,9 года). Частота кровоизлияний в суставы у пациентов после 1 года жизни ― 2−3 раза в год. МРТ (Toshiba Excel Art Vantage, 1,5 Т) выполнена 13 пациентам (35 суставов; 57 исследований). Контрольное наблюдение проведено через 1; 2 или 3 года в зависимости от частоты гемартрозов в течение года и выявленной первично тяжести поражения суставов. Результаты. Полученные результаты включали как положительные сдвиги в виде стабилизации состояния внутрисуставных структур, так и отрицательные динамические изменения. С помощью МРТ показано, что снижение частоты кровоизлияний в суставы на фоне заместительной гемостатической терапии приводит к стиханию воспалительных процессов в суставе и достоверному уменьшению количества внутрисуставного выпота (n = 11; р = 0,03), уменьшению числа суставов с признаками отека костного мозга (n = 8), отсутствию отрицательной динамики в виде утолщения синовиальной оболочки. Отрицательная динамика в состоянии суставов (увеличение глубины и протяженности эрозивного процесса: n = 5; 22,7%; дегенеративные изменения менисков и связок: n = 2; 9%) при условии регулярного введения факторов свертывания связана с развитием ингибиторной формы заболевания, что подтверждалось лабораторными данными. Заключение. Магнитно-резонансная томография позволяет оценить эффективность заместительной терапии у  детей с гемофилией.</p><p> </p></abstract><trans-abstract xml:lang="en"><p>Modifications in treatment guidelines of hemophilic arthropathy changed the role of diagnostic X-ray imaging methods. Diagnostic methods are used both for determination of the degree of joint destruction and long-term evaluation of the joint conditions and therapy adequacy and effectiveness. Aim. Magnetic resonance imaging (MRI) dynamics for joint condition assessment in children with hemophilic arthropathy receiving prophylactic factor replacement therapy concentrated rolling VIII. Materials and methods. We studied 13 boys aged 5 to 14 years (mean age 8.9 years) with hemophilia type A severe form of the disease (factor VIII deficiency &lt;1%) at the baseline. The average age of appearance of hemarthrosis is 2.1 years (from 1.8 to 2.9 years). The frequency of bleeding into the joints of patients older than 1 year was 2-3 times per year. Magnetic resonance imaging (ToshibaExcelArtVantage, 1,5 T) was performed in 13 patients, 35 joints were examined, 57 studies were executed. Control study of joints was conducted in 1, 2 or 3 years depending on the frequency of hemarthrosis during the year and the severity of joint damage primarily identified. Results. The results included both the improvement along with the stabilization of intra-state structures and the negative dynamic shifts. MRI showed that the reduction of bleeding in the joints on the background of hemostatic replacement therapy led to subsiding inflammation in the joints and significant decrease in the amount of intra-articular effusion (n = 11; p = 0.03), decrease in the number of joints with symptoms of bone marrow edema (n = 8), the absence of observations with negative changes in the form of increasing the thickness of the synovial membrane. Negative dynamics of joint condition presented as increasing of the depth and length of erosive process (n = 5; 22.7%), degenerative changes in ligaments and menisci (n = 2; 9%) under the condition of regular administration of clotting factors was associated with the development of the inhibitory form of the disease which was confirmed by laboratory data. Conclusions. Magnetic resonance imaging evaluates the effectiveness of replacement therapy in children with hemophilia.</p><p> </p></trans-abstract><kwd-group xml:lang="ru"><kwd>гемофилия</kwd><kwd>гемофилическая артропатия</kwd><kwd>заместительная гемостатическая терапия</kwd><kwd>магнитно-резонансная томография</kwd><kwd>изменения суставов в динамике</kwd></kwd-group><kwd-group xml:lang="en"><kwd>hemophilia</kwd><kwd>hemophilic arthropathy</kwd><kwd>replacement hemostatic therapy</kwd><kwd>magnetic resonance imaging</kwd><kwd>the changes in the joint dynamics</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Андреев Ю. Н. Многоликая гемофилия. Москва: Ньюдиамед. 2006. 232 с.</mixed-citation><mixed-citation xml:lang="en">Andreev Yu.N. Mnogolikaya gemofiliya [The Many Faces of Hemophilia]. Moscow, N'yudiamed, 2006. 232 p.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Lobet S., Hermans C., Lambert C. Optimal management of hemophilic arthropathy and hematomas. Journal of Blood Medicine.2014; 5: 207–218.</mixed-citation><mixed-citation xml:lang="en">Lobet S., Hermans C., Lambert C. Optimal management of hemophilic arthropathy and hematomas. Journal of Blood Medicine. 2014; 5: 207−218.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Monahan P. E., Doria A. S., Ljung R., Jimenez-Yuste V. Optimizing joint function: new knowledge and novel tools and treatments.</mixed-citation><mixed-citation xml:lang="en">Monahan P.E., Doria A.S., Ljung R., Jiménez-Yuste V. Optimizing joint function: new knowledge and novel tools and treatments. Haemophilia. 2012 Jul; 18 (Suppl. 5): 17−26.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Haemophilia. 2012 Jul; 18 (Suppl. 5): 17–26.</mixed-citation><mixed-citation xml:lang="en">Valentino L.A. The benefits of prophylactic treatment with APCC in patients with haemophilia and high-titre inhibitors: a retrospective case series. Haemophilia. 2009 May; 15 (3): 733−42.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Valentino L. A. The benefits of prophylactic treatment with APCC in patients with haemophilia and high-titre inhibitors: a retrospective case series. Haemophilia. 2009 May; 15 (3): 733–42.</mixed-citation><mixed-citation xml:lang="en">Acharya S.S. Hemophilic joint disease ― current perspective and potential future strategies. Transfus Apher Sci. 2008 Feb; 38 (1): 49−55.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Acharya S. S. Hemophilic joint disease — current perspective and potential future strategies. Transfus Apher Sci. 2008 Feb;</mixed-citation><mixed-citation xml:lang="en">Tret'yakova O.S. Hemophilia in children: current approaches to treatment and prevention. Dityachii Likar = Pediatrician. 2012; 6: 26−32.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">(1): 49–55.</mixed-citation><mixed-citation xml:lang="en">Rodriguez-Merchan E.C., Jimenez-Yuste V., Aznar J.A., Hedner U., Knobe K., Lee C.A., Ljung R., Querol F., Santagostino E., Valentino L.A., Caffarini A. Joint protection in haemophilia. Haemophilia. 2011 Sep; 17 (Suppl. 2): 1−23.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Третьякова О. С. Гемофилия у детей: современные подходы к лечению и профилактике. Дитячий Лiкар. 2012; 6: 26–32.</mixed-citation><mixed-citation xml:lang="en">Franchini M., Mannucc M. Past, present and future of hemophilia: a narrative review. Orphanet J of Rare Dis. 2012; 7: 24.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Rodriguez-Merchan E. C., Jimenez-Yuste V., Aznar J. A., Hedner U., Knobe K., Lee C. A., Ljung R., Querol F., Santagostino E., Valentino L. A., Caffarini A. Joint protection in haemophilia. Haemophilia. 2011 Sep; 17 (Suppl. 2): 1–23.</mixed-citation><mixed-citation xml:lang="en">Bryukhanov A.V., Vasil'ev A.Yu. Magnitno-rezonansnaya tomografiya v diagnostike zabolevanii sustavov [Magnetic resonance imaging in the diagnosis of diseases of the joints]. Barnaul, Altaiskii poligraficheskii kombinat, 2001. 198 p.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Franchini M., Mannucc M. Past, present and future of hemophilia: a narrative review. Orphanet J of Rare Dis. 2012; 7: 24.</mixed-citation><mixed-citation xml:lang="en">Pergantou H., Platokouki H., Matsinos G., Papakonstantinou O., Papadopoulos A., Xafaki P., Petratos D., Aronis S. Assessment of the progression of haemophilicarthropathy in children. Haemophilia. 2010 Jan; 16 (1): 124−9.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Брюханов А. В., Васильев А. Ю. Магнитно-резонансная томография в диагностике заболеваний суставов. Барнаул: Алтайский полиграфический комбинат. 2001. 198 с.</mixed-citation><mixed-citation xml:lang="en">Cross S., Vaidya S., Fotiadis N. Hemophilic arthropathy: a review of imaging and staging. Semin Ultrasound CT MR. 2013 Dec; 34 (6): 516−24.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Pergantou H., Platokouki H., Matsinos G., Papakonstantinou O., Papadopoulos A., Xafaki P., Petratos D., Aronis S. Assessment of the progression of haemophilicarthropathy in children. Haemophilia. 2010 Jan; 16 (1): 124–9.</mixed-citation><mixed-citation xml:lang="en">Oymak Y., Yildirim A.T., Yaman Y., Gurcinar M., Firat A., Cubuckcu D., Carti O., Ozek G., Vergin R.C. The Effectiveness of Tools for Monitoring Hemophilic Arthropathy. J Pediatr Hematol Oncol. 2014 Oct; 3: 157−159.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Cross S., Vaidya S., Fotiadis N. Hemophilic arthropathy: a review of imaging and staging. Semin Ultrasound CT MR. 2013 Dec; 34 (6): 516–24.</mixed-citation><mixed-citation xml:lang="en">Cross S., Vaidya S., Fotiadis N. Hemophilic arthropathy: a review of imaging and staging. Semin Ultrasound CT MR. 2013 Dec; 34 (6): 516–24.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Oymak Y., Yildirim A. T., Yaman Y., Gurcinar M., Firat A., Cubuckcu D., Carti O., Ozek G., Vergin R. C. The Effectiveness of Tools for Monitoring Hemophilic Arthropathy. J Pediatr Hematol Oncol. 2014 Oct; 3: 157–159.</mixed-citation><mixed-citation xml:lang="en">Oymak Y., Yildirim A. T., Yaman Y., Gurcinar M., Firat A., Cubuckcu D., Carti O., Ozek G., Vergin R. C. The Effectiveness of Tools for Monitoring Hemophilic Arthropathy. J Pediatr Hematol Oncol. 2014 Oct; 3: 157–159.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Андреев Ю. Н. Многоликая гемофилия. Москва: Ньюдиамед. 2006. 232 с.</mixed-citation><mixed-citation xml:lang="en">Андреев Ю. Н. Многоликая гемофилия. Москва: Ньюдиамед. 2006. 232 с.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Lobet S., Hermans C., Lambert C. Optimal management of hemophilic arthropathy and hematomas. Journal of Blood Medicine.2014; 5: 207–218.</mixed-citation><mixed-citation xml:lang="en">Lobet S., Hermans C., Lambert C. Optimal management of hemophilic arthropathy and hematomas. Journal of Blood Medicine.2014; 5: 207–218.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Monahan P. E., Doria A. S., Ljung R., Jimenez-Yuste V. Optimizing joint function: new knowledge and novel tools and treatments.</mixed-citation><mixed-citation xml:lang="en">Monahan P. E., Doria A. S., Ljung R., Jimenez-Yuste V. Optimizing joint function: new knowledge and novel tools and treatments.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Haemophilia. 2012 Jul; 18 (Suppl. 5): 17–26.</mixed-citation><mixed-citation xml:lang="en">Haemophilia. 2012 Jul; 18 (Suppl. 5): 17–26.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Valentino L. A. The benefits of prophylactic treatment with APCC in patients with haemophilia and high-titre inhibitors: a retrospective case series. Haemophilia. 2009 May; 15 (3): 733–42.</mixed-citation><mixed-citation xml:lang="en">Valentino L. A. The benefits of prophylactic treatment with APCC in patients with haemophilia and high-titre inhibitors: a retrospective case series. Haemophilia. 2009 May; 15 (3): 733–42.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Acharya S. S. Hemophilic joint disease — current perspective and potential future strategies. Transfus Apher Sci. 2008 Feb;</mixed-citation><mixed-citation xml:lang="en">Acharya S. S. Hemophilic joint disease — current perspective and potential future strategies. Transfus Apher Sci. 2008 Feb;</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">(1): 49–55.</mixed-citation><mixed-citation xml:lang="en">(1): 49–55.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Третьякова О. С. Гемофилия у детей: современные подходы к лечению и профилактике. Дитячий Лiкар. 2012; 6: 26–32.</mixed-citation><mixed-citation xml:lang="en">Третьякова О. С. Гемофилия у детей: современные подходы к лечению и профилактике. Дитячий Лiкар. 2012; 6: 26–32.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Rodriguez-Merchan E. C., Jimenez-Yuste V., Aznar J. A., Hedner U., Knobe K., Lee C. A., Ljung R., Querol F., Santagostino E., Valentino L. A., Caffarini A. Joint protection in haemophilia. Haemophilia. 2011 Sep; 17 (Suppl. 2): 1–23.</mixed-citation><mixed-citation xml:lang="en">Rodriguez-Merchan E. C., Jimenez-Yuste V., Aznar J. A., Hedner U., Knobe K., Lee C. A., Ljung R., Querol F., Santagostino E., Valentino L. A., Caffarini A. Joint protection in haemophilia. Haemophilia. 2011 Sep; 17 (Suppl. 2): 1–23.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Franchini M., Mannucc M. Past, present and future of hemophilia: a narrative review. Orphanet J of Rare Dis. 2012; 7: 24.</mixed-citation><mixed-citation xml:lang="en">Franchini M., Mannucc M. Past, present and future of hemophilia: a narrative review. Orphanet J of Rare Dis. 2012; 7: 24.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Брюханов А. В., Васильев А. Ю. Магнитно-резонансная томография в диагностике заболеваний суставов. Барнаул: Алтайский полиграфический комбинат. 2001. 198 с.</mixed-citation><mixed-citation xml:lang="en">Брюханов А. В., Васильев А. Ю. Магнитно-резонансная томография в диагностике заболеваний суставов. Барнаул: Алтайский полиграфический комбинат. 2001. 198 с.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Pergantou H., Platokouki H., Matsinos G., Papakonstantinou O., Papadopoulos A., Xafaki P., Petratos D., Aronis S. Assessment of the progression of haemophilicarthropathy in children. Haemophilia. 2010 Jan; 16 (1): 124–9.</mixed-citation><mixed-citation xml:lang="en">Pergantou H., Platokouki H., Matsinos G., Papakonstantinou O., Papadopoulos A., Xafaki P., Petratos D., Aronis S. Assessment of the progression of haemophilicarthropathy in children. Haemophilia. 2010 Jan; 16 (1): 124–9.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Cross S., Vaidya S., Fotiadis N. Hemophilic arthropathy: a review of imaging and staging. Semin Ultrasound CT MR. 2013 Dec; 34 (6): 516–24.</mixed-citation><mixed-citation xml:lang="en">Cross S., Vaidya S., Fotiadis N. Hemophilic arthropathy: a review of imaging and staging. Semin Ultrasound CT MR. 2013 Dec; 34 (6): 516–24.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Oymak Y., Yildirim A. T., Yaman Y., Gurcinar M., Firat A., Cubuckcu D., Carti O., Ozek G., Vergin R. C. The Effectiveness of Tools for Monitoring Hemophilic Arthropathy. J Pediatr Hematol Oncol. 2014 Oct; 3: 157–159.</mixed-citation><mixed-citation xml:lang="en">Oymak Y., Yildirim A. T., Yaman Y., Gurcinar M., Firat A., Cubuckcu D., Carti O., Ozek G., Vergin R. C. The Effectiveness of Tools for Monitoring Hemophilic Arthropathy. J Pediatr Hematol Oncol. 2014 Oct; 3: 157–159.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Андреев Ю. Н. Многоликая гемофилия. Москва: Ньюдиамед. 2006. 232 с.</mixed-citation><mixed-citation xml:lang="en">Андреев Ю. Н. Многоликая гемофилия. Москва: Ньюдиамед. 2006. 232 с.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Lobet S., Hermans C., Lambert C. Optimal management of hemophilic arthropathy and hematomas. Journal of Blood Medicine.2014; 5: 207–218.</mixed-citation><mixed-citation xml:lang="en">Lobet S., Hermans C., Lambert C. Optimal management of hemophilic arthropathy and hematomas. Journal of Blood Medicine.2014; 5: 207–218.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Monahan P. E., Doria A. S., Ljung R., Jimenez-Yuste V. Optimizing joint function: new knowledge and novel tools and treatments.</mixed-citation><mixed-citation xml:lang="en">Monahan P. E., Doria A. S., Ljung R., Jimenez-Yuste V. Optimizing joint function: new knowledge and novel tools and treatments.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Haemophilia. 2012 Jul; 18 (Suppl. 5): 17–26.</mixed-citation><mixed-citation xml:lang="en">Haemophilia. 2012 Jul; 18 (Suppl. 5): 17–26.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Valentino L. A. The benefits of prophylactic treatment with APCC in patients with haemophilia and high-titre inhibitors: a retrospective case series. Haemophilia. 2009 May; 15 (3): 733–42.</mixed-citation><mixed-citation xml:lang="en">Valentino L. A. The benefits of prophylactic treatment with APCC in patients with haemophilia and high-titre inhibitors: a retrospective case series. Haemophilia. 2009 May; 15 (3): 733–42.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Acharya S. S. Hemophilic joint disease — current perspective and potential future strategies. Transfus Apher Sci. 2008 Feb;</mixed-citation><mixed-citation xml:lang="en">Acharya S. S. Hemophilic joint disease — current perspective and potential future strategies. Transfus Apher Sci. 2008 Feb;</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">(1): 49–55.</mixed-citation><mixed-citation xml:lang="en">(1): 49–55.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Третьякова О. С. Гемофилия у детей: современные подходы к лечению и профилактике. Дитячий Лiкар. 2012; 6: 26–32.</mixed-citation><mixed-citation xml:lang="en">Третьякова О. С. Гемофилия у детей: современные подходы к лечению и профилактике. Дитячий Лiкар. 2012; 6: 26–32.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Rodriguez-Merchan E. C., Jimenez-Yuste V., Aznar J. A., Hedner U., Knobe K., Lee C. A., Ljung R., Querol F., Santagostino E., Valentino L. A., Caffarini A. Joint protection in haemophilia. Haemophilia. 2011 Sep; 17 (Suppl. 2): 1–23.</mixed-citation><mixed-citation xml:lang="en">Rodriguez-Merchan E. C., Jimenez-Yuste V., Aznar J. A., Hedner U., Knobe K., Lee C. A., Ljung R., Querol F., Santagostino E., Valentino L. A., Caffarini A. Joint protection in haemophilia. Haemophilia. 2011 Sep; 17 (Suppl. 2): 1–23.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Franchini M., Mannucc M. Past, present and future of hemophilia: a narrative review. Orphanet J of Rare Dis. 2012; 7: 24.</mixed-citation><mixed-citation xml:lang="en">Franchini M., Mannucc M. Past, present and future of hemophilia: a narrative review. Orphanet J of Rare Dis. 2012; 7: 24.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Брюханов А. В., Васильев А. Ю. Магнитно-резонансная томография в диагностике заболеваний суставов. Барнаул: Алтайский полиграфический комбинат. 2001. 198 с.</mixed-citation><mixed-citation xml:lang="en">Брюханов А. В., Васильев А. Ю. Магнитно-резонансная томография в диагностике заболеваний суставов. Барнаул: Алтайский полиграфический комбинат. 2001. 198 с.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Pergantou H., Platokouki H., Matsinos G., Papakonstantinou O., Papadopoulos A., Xafaki P., Petratos D., Aronis S. Assessment of the progression of haemophilicarthropathy in children. Haemophilia. 2010 Jan; 16 (1): 124–9.</mixed-citation><mixed-citation xml:lang="en">Pergantou H., Platokouki H., Matsinos G., Papakonstantinou O., Papadopoulos A., Xafaki P., Petratos D., Aronis S. Assessment of the progression of haemophilicarthropathy in children. Haemophilia. 2010 Jan; 16 (1): 124–9.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Cross S., Vaidya S., Fotiadis N. Hemophilic arthropathy: a review of imaging and staging. Semin Ultrasound CT MR. 2013 Dec; 34 (6): 516–24.</mixed-citation><mixed-citation xml:lang="en">Cross S., Vaidya S., Fotiadis N. Hemophilic arthropathy: a review of imaging and staging. Semin Ultrasound CT MR. 2013 Dec; 34 (6): 516–24.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Oymak Y., Yildirim A. T., Yaman Y., Gurcinar M., Firat A., Cubuckcu D., Carti O., Ozek G., Vergin R. C. The Effectiveness of Tools for Monitoring Hemophilic Arthropathy. J Pediatr Hematol Oncol. 2014 Oct; 3: 157–159.</mixed-citation><mixed-citation xml:lang="en">Oymak Y., Yildirim A. T., Yaman Y., Gurcinar M., Firat A., Cubuckcu D., Carti O., Ozek G., Vergin R. C. The Effectiveness of Tools for Monitoring Hemophilic Arthropathy. J Pediatr Hematol Oncol. 2014 Oct; 3: 157–159.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
